bpc-157 and prostate cancer A novel peptide explicitly induces cell death by destabilizing AR inhibiting AR-mediated transcription BPC-157 – Mark Hyman, MD

HbA1c reductions of 1.5-2.5 percentage points are common

This peptide has shown a lot of promise and is generally well-tolerated when used properly and under the care of a qualified healthcare provider, so its an easy one to put on your short list

SeekPeptides encourages evidence-based decision-making and provides members with regularly updated research summaries as new data becomes available

VGPR, very good partial response

Prez B, Medrano C, Ecay MJ, Ruiz-Sala P, Martnez-Pardo M, Ugarte M, Prez-Cerd C

Topical side effects: - Mild scalp redness or irritation (5 to 10% of users), typically resolves within days - Temporary shedding increase during the first 2 weeks (adjustment phase) - Contact dermatitis in rare cases, usually from other ingredients in the serum formulation Injectable side effects: - Injection site redness or swelling (resolves within hours) - Mild headache in the first week of use (uncommon) - See the GHK-Cu injection dosage guide for full safety data The copper uglies explained: This is the most important side effect to understand